Role of carnitine in cancer chemotherapy-induced multiple organ toxicity.

  title={Role of carnitine in cancer chemotherapy-induced multiple organ toxicity.},
  author={Mohamed M Sayed-Ahmed},
  journal={Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society},
  volume={18 4},
  • M. Sayed-Ahmed
  • Published 1 October 2010
  • Biology, Medicine
  • Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Figures from this paper

Identifying cisplatin-induced kidney damage in paediatric oncology patients

The effect of cisplatin-induced nephrotoxicity (Cis-N) in children and the underlying mechanisms are considered and the importance of magnesium homeostasis and supplementation is focused on.

How does chemotherapy treatment damage the prepubertal testis?

Understanding of how chemotherapy agents target the prepubertal testis will provide clarity to patients on the gonadotoxicity of different drugs and aid in the development of cytoprotective agents.

Potential nephroprotective effects of l-carnitine against drug-induced nephropathy: a review of literature

Introduction: Drug-induced nephrotoxicity (DIN) has been reported with a great number of medications and contributes to ∼ 20% of hospital admissions. l-carnitine owing to its antioxidant,


The liver of epirubicin treated mice showed histological abnormalities, and these were also ameliorated by the treatment with silymarin, especially the 100mg/kg dose.

Modulatory effects of l-carnitine on tamoxifen toxicity and oncolytic activity

The aim of this study was to investigate the protective effect of l-carnitine (l-CAR) in tamoxifen (TAM)-induced toxicity and antitumor activity. Adult female rats were randomly divided into four

Micronutrients in Oncological Intervention

Recent studies have provided increasing evidence that treatment is tolerated better—with an increase in patient compliance and a lower rate of treatment discontinuations—when micronutrients are added as appropriate to the patient’s medication.

Carnitine partially protects the rat testis against the late damage produced by doxorubicin administered during pre‐puberty

Carnitine reduced the late testicular and spermatic damages caused by doxorubicin, probably providing a partial cytoprotection against the deleterious action of doxorbicin administration to pre‐pubertal rats.

Protective Effects of Olmesartan and L-carnitine on Doxorubicin-Induced Cardiotoxicity in Rats.

The present study data confirms the protective role of L-CA and Olm in DOX-induced cardiotoxicity, and shows a significant elevation in serum troponin I, CK-MB, and LDH, together with increased inflammation manifested by the rise of TNF-α, ICAM-1, IL-1 and TGF-β in cardiac tissues.

1H NMR based metabolomic approach to monitoring of the head and neck cancer treatment toxicity

NMR-based metabolomics provides relevant biomarkers of RT/CHRT toxicity (ARS) in HNSCC patients and indicates an exciting potential of J-resolved NMR spectroscopy combined with multivariate projection techniques.



Effects of doxorubicin-containing chemotherapy and a combination with l-carnitine on oxidative metabolism in patients with non-Hodgkin lymphoma

Biochemical and molecular analyses indicated a stimulation of oxidative metabolism in white blood cells through carnitine uptake in patients treated with anthracycline regimens.

Serum carnitine levels in patients with tumoral cachexia.

A Pilot Study on the Effect of Acetyl-L-Carnitine in Paclitaxel-And Cisplatin-Induced Peripheral Neuropathy

Acetyl-L-carnitine seems to be an effective and well-tolerated agent for the treatment of chemotherapy-induced peripheral neuropathy, and preliminary results should be confirmed in double-blind, placebo controlled studies.

Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine.

It is indicated that ALC is a specific protective agent for chemotherapy-induced neuropathy after cisplatin or paclitaxel treatment without showing any interference with the antitumor activity of the drugs.

Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients

In selected patients, levocarnitine supplementation may be effective in alleviating chemotherapy-induced fatigue, and this compound deserves further investigations in a randomised, placebo-controlled study.

Increased urinary excretion of carnitine in patients treated with cisplatin

Treatment with cisplatin is associated with a tenfold increase in renal carnitine excretion, most likely due to inhibition of carn itine reabsorption by the proximal tubule of the nephron.

L-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine.

Reduction of cardiac toxicity of anthracyclines by L-carnitine: preliminary overview of clinical data.

The systematic use of L-carnitine as adjuvant therapy is proposed during doxorubicin administration to prevent acute and chronic cardiotoxicity.

Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs.

  • M. HaschkeTanja Vitins S. Krähenbühl
  • Medicine, Biology
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2010
All platin derivatives investigated are associated with renal tubular damage in humans without significantly affecting glomerular function.

Serum carnitine levels during the doxorubicin therapy. Its role in cardiotoxicity.

There was a trend towards lower serum carnitine levels with higher cumulative doses of doxorubicin, although it was not statistically significant, and the results invite new detailed investigations depending on the measurement of serum and urinary free and acyl carnitines and myocardial carnitined levels.